Design, click synthesis, and biological evaluation of novel uracil-1,2,3-triazole hybrids as dual EGFR/CDK1 inhibitors: antiproliferative activity, mechanistic insights, and <i>in silico</i> studies.

Mohamed AH, Aly AA, Abdelhafez EMN, Fouly AA, Brown AB, Gedamy SA.

Open source

DOI
10.1039/d6ra09088e
Published
2026-11-03
Container
RSC Adv
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6ra09088e,
  title = {Design, click synthesis, and biological evaluation of novel uracil-1,2,3-triazole hybrids as dual EGFR/CDK1 inhibitors: antiproliferative activity, mechanistic insights, and \<i\>in silico\</i\> studies.},
  author = {Mohamed AH and  Aly AA and  Abdelhafez EMN and  Fouly AA and  Brown AB and  Gedamy SA.},
  year = {2026},
  journal = {RSC Adv},
  doi = {10.1039/d6ra09088e},
  url = {https://doi.org/10.1039/d6ra09088e}
}

RIS

TY  - JOUR
TI  - Design, click synthesis, and biological evaluation of novel uracil-1,2,3-triazole hybrids as dual EGFR/CDK1 inhibitors: antiproliferative activity, mechanistic insights, and <i>in silico</i> studies.
AU  - Mohamed AH
AU  -  Aly AA
AU  -  Abdelhafez EMN
AU  -  Fouly AA
AU  -  Brown AB
AU  -  Gedamy SA.
PY  - 2026
JO  - RSC Adv
DO  - 10.1039/d6ra09088e
UR  - https://doi.org/10.1039/d6ra09088e
ER  - 

APA

AH, M., AA, A., EMN, A., AA, F., AB, B., & SA., G. (2026). Design, click synthesis, and biological evaluation of novel uracil-1,2,3-triazole hybrids as dual EGFR/CDK1 inhibitors: antiproliferative activity, mechanistic insights, and <i>in silico</i> studies.. RSC Adv. https://doi.org/10.1039/d6ra09088e

Source records